Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FPHAX vs. FHLC: which is better?

Bottom line

FPHAX vs FHLC: the short answer

FPHAX (Pharmaceuticals Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are quite different portfolios: only about 30% of their top holdings (by weight) are shared.

But FHLC is far broader, holding 337 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.

FHLC is cheaper at 0.084% vs 0.67% — a difference of $59 a year per $10,000 invested.

Over five years, FPHAX returned +12.6% a year vs +7.2% for FHLC (reporting dates differ).

Updated Nov 19, 2026

FPHAX vs FHLC side by side

FPHAXFHLC
TypeMutual fundETF
Fund familyFidelityFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.67%0.084%
Annual cost per $10k$67$8.4
10-yr cost on $10k (prospectus)$835$108
Max front load—None
12b-1 fee0%0%
1-yr return+30.3%+2.6%
5-yr return (annualized)+12.6%+7.2%
10-yr return (annualized)+10.0%+8.8%
Best quarter+18.5%+16.4%
Worst quarter−13.6%−13.1%
Net assets (fund)$1.5B$3.3B
Number of holdings57337
Portfolio turnover77%3%
Returns as ofApr 30, 2026Nov 30, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFPHAXFHLCDifference
2024+9.4%+2.6%+6.8%
2023+12.5%+2.5%+10.0%
2022+1.0%−5.5%+6.4%
2021+11.8%+20.4%−8.5%
2020+11.1%+18.1%−7.1%
2019+31.6%+21.9%+9.7%
2018+5.8%+5.5%+0.3%
2017+10.7%+23.3%−12.6%
2016−16.3%−3.3%−12.9%

Source: Fund prospectus bar charts

Holdings overlap

4 of FPHAX's top 25 holdings also appear in FHLC's top 25.

Shared top holdings
HoldingFPHAXFHLC
ELI LILLY and CO28.78%13.35%
MERCK and CO INC4.74%4.66%
Gilead Sciences Inc3.97%2.34%
JOHNSON and JOHNSON3.77%8.93%

Source: SEC Form N-PORT

FPHAX top 10

  1. ELI LILLY and CO — 28.78%
  2. Gsk Plc — 8.17%
  3. Viatris Inc — 5.45%
  4. Ucb Sa — 5.09%
  5. MERCK and CO INC — 4.74%
  6. Roche Holding Ag — 4.54%
  7. Legend Biotech Corp — 4.53%
  8. Astrazeneca Plc — 4.22%
  9. Elanco Animal Health Inc — 4.15%
  10. Jazz Pharmaceuticals Plc — 4.09%

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

FAQ

What is the difference between FPHAX and FHLC?
FPHAX (Pharmaceuticals Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are quite different portfolios: only about 30% of their top holdings (by weight) are shared. But FHLC is far broader, holding 337 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.
Which is cheaper, FPHAX or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both FPHAX and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.